Natsuko Kameyama

Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination

BACKGROUND: Risk management plans (RMPs) support lifecycle management of drug-related risks. In Japan, however, their use in clinical practice remains limited, and healthcare professionals often rely on the package insert for safety information. After RMP termination at re-examin...